title: Combination of daclatasvir and sofosbuvir for hepatitis C genotypes 1, 2, and 3.
authors: Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
authors: Khurram
authors: K
authors: Bari
authors: Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
authors: Pratima
authors: P
authors: Sharma
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000998:Antiviral Agents; D007093:Imidazoles; D017361:Viral Nonstructural Proteins; D014542:Uridine Monophosphate